Hope and Concern

To some people, three-person IVF or mitochondrial replacement is hope for preventing mitochondrial diseases from being passed on to the next generation, while to others, it is the beginning of the development of designer babies, the New York Times Magazine says.

In the US, the Food and Drug Administration regulates this technique, and recently held a hearing to consider allowing clinical trials of mitochondrial replacement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.